XML 32 R20.htm IDEA: XBRL DOCUMENT
v3.20.2

Summary of Significant Accounting Policies (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2020
Accounting Policies [Abstract] |
Schedule of credit and concentration risks |
Customer |  | Percentage of Sales |
|  | September 30, 2020 |  |  | September 30, 2019 |
|  | (Unaudited) |  |  | (Unaudited) |
1 |  |  | 25.8 |  |  |  | 35.0 |
2 |  |  | 23.2 |  |  |  | 26.7 |
3 |  |  | 21.6 |  |  |  | * |
| * | Customer was less than 10% of sales for the three months ended September 30, 2019.
Customer |  | Percentage of Sales |
|  | September 30, 2020 |  |  | September 30, 2019 |
|  | (Unaudited) |  |  | (Unaudited) |
1 |  |  | 32.1 |  |  |  | 31.1 |
2 |  |  | 28.2 |  |  |  | 31.0 |
3 |  |  | 13.9 |  |  |  | * |
4 |  |  | * |  |  |  | 11.3 |
| * | Customer was less than 10% of sales for the nine months ended September 30, 2020 and 2019.
Customer |  | Percentage of Receivables |
|  | September 30, 2020 |  |  | December 31, 2019 |
|  | (Unaudited) |  |  |  |
1 |  |  | 34.6 |  |  |  | 32.7 |
2 |  |  | 29.0 |  |  |  | 10.0 |
3 |  |  | * |  |  |  | 25.1 |
| * | Customer was less than 10% of accounts receivable sales at September 30, 2020.
Schedule of calculation of net income (loss) applicable to common stockholders utilized to calculate EPS |
|  | Three Months Ended |  |  | Nine Months Ended |
|  | Sept 30, 2020 |  |  | Sept 30, 2019 |  |  | Sept 30, 2020 |  |  | Sept 30, 2019 |
Continuing Operations |  | (Unaudited) |  |  | (Unaudited) |  |  | (Unaudited) |  |  | (Unaudited) |
Income (loss) from continuing operations |  | $ | (477,000 | ) |  | $ | 398,000 |  |  | $ | (1,003,000 | ) |  | $ | (1,332,000 | )
Add: Convertible Note Interest for Potential Note Conversion |  |  | - |  |  |  | 120,000 |  |  |  | - |  |  |  | - |
Income (loss) used to calculate earnings per share |  | $ | (477,000 | ) |  | $ | 518,000 |  |  | $ | (1,003,000 | ) |  | $ | (1,332,000 | )
Schedule of earnings per share for continuing operations |
|  | Three Months Ended |  |  | Nine Months Ended |
|  | September 30, 2020 |  |  | September 30, 2019 |  |  | September 30, 2020 |  |  | September 30, 2019 |
Continuing Operations |  | (Unaudited) |  |  | (Unaudited) |  |  | (Unaudited) |  |  | (Unaudited) |
Weighted average shares outstanding used to compute basic earnings per share |  |  | 30,620,990 |  |  |  | 28,909,072 |  |  |  | 30,524,874 |  |  |  | 28,774,041 |
Effect of dilutive stock options and warrants |  |  | - |  |  |  | 131,458 |  |  |  | - |  |  |  | - |
Effect of dilutive convertible notes payable |  |  | - |  |  |  | 6,005,485 |  |  |  | - |  |  |  | - |
Weighted average shares outstanding and dilutive securities used to compute dilutive earnings per share |  |  | 30,620,990 |  |  |  | 35,046,015 |  |  |  | 30,524,874 |  |  |  | 28,774,041 |
Schedule of anti-dilutive securities |
|  | Three and Nine Months Ended |
|  | September 30, 2020 |  |  | September 30, 2019 |
|  | (Unaudited) |  |  | (Unaudited) |
Stock Options |  |  | 163,000 |  |  |  | 852,000 |
Warrants |  |  | 1,423,000 |  |  |  | 2,183,000 |
|  |  | 1,586,000 |  |  |  | 3,035,000 |
|  | Three Months Ended |  |  | Nine Months Ended |
|  | September 30, 2020 |  |  | September 30, 2019 |  |  | September 30, 2020 |  |  | September 30, 2019 |
|  | (Unaudited) |  |  | (Unaudited) |  |  | (Unaudited) |  |  | (Unaudited) |
Stock Options |  |  | 1,696,000 |  |  |  | - |  |  |  | 1,696,000 |  |  |  | 500,000 |
Warrants |  |  | 760,000 |  |  |  | - |  |  |  | 760,000 |  |  |  | - |
Convertible notes payable |  |  | 5,092,000 |  |  |  | - |  |  |  | 5,092,000 |  |  |  | 6,005,000 |
|  |  | 7,548,000 |  |  |  | - |  |  |  | 7,548,000 |  |  |  | 6,505,000

X
- Definition Tabular disclosure of anti dilutive securities. + References No definition available. + Details
Name: | airi_AntidilutiveSecuritiesTableTextBlock
Namespace Prefix: | airi_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_AccountingPoliciesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 + Details
Name: | us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 21 -URI http://asc.fasb.org/extlink&oid=121572278&loc=d3e13537-108611 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 20 -URI http://asc.fasb.org/extlink&oid=121572278&loc=d3e13531-108611 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 20 -URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 16 -URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592 Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 18 -URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592 Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 21 -URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592 + Details
Name: | us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration